About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [467 citations: 1–100 of 419 articles]

Articles published in Schizophrenia Research and Treatment have been cited 467 times. The following is a list of the 419 articles that have cited the articles published in Schizophrenia Research and Treatment.

  • Joseph E. Pero, Michael A. Rossi, Michael J. Kelly, Hannah D. G. F. Lehman, Mark E. Layton, Robert M. Garbaccio, Julie A. O’Brien, Brian C. Magliaro, Jason M. Uslaner, Sarah L. Huszar, Kerry L. Fillgrove, Cuyue Tang, Yuhsin Kuo, Leo A. Joyce, Edward C. Sherer, and Marlene A. Jacobson, “Optimization of Novel Aza-benzimidazolone mGluR2 PAMs with Respect to LLE and PK Properties and Mitigation of CYP TDI,” ACS Medicinal Chemistry Letters, 2016. View at Publisher · View at Google Scholar
  • Amany I. Shehata, Faika I. Hassanein, and Rashad Abdul-Ghani, “Seroprevalence of Toxoplasma gondii infection among patients with non-schizophrenic neurodevelopmental disorders in Alexandria, Egypt,” Acta Tropica, vol. 154, pp. 155–159, 2016. View at Publisher · View at Google Scholar
  • Tak Lam Lo, Matthew Warden, Yanling He, Tianmei Si, Seshadri Kalyanasundaram, Manickam Thirunavukarasu, Nurmiati Amir, Ahmad Hatim, Tomas Bautista, Cheng Lee, Robin Emsley, Jose Olivares, Yen Kuang Yang, Ronnachai Kongsakon, and David Castle, “Recommendations for the optimal care of patients with recent-onset psychosis in the Asia-Pacific region,” Asia-Pacific Psychiatry, vol. 8, no. 2, pp. 154–171, 2016. View at Publisher · View at Google Scholar
  • Guusje Collin, Elise Turk, and Martijn P. van den Heuvel, “Connectomics in schizophrenia: from early pioneers to recent brain network findings,” Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 2016. View at Publisher · View at Google Scholar
  • Wenyi Qin, Cong Liu, Monsheel Sodhi, and Hui Lu, “Meta-analysis of sex differences in gene expression in schizophrenia,” Bmc Systems Biology, vol. 10, 2016. View at Publisher · View at Google Scholar
  • Ana P. Pinheiro, Neguine Rezaii, Paul G. Nestor, Andréia Rauber, Kevin M. Spencer, and Margaret Niznikiewicz, “Did you or I say pretty, rude or brief? An ERP study of the effects of speaker’s identity on emotional word processing,” Brain and Language, vol. 153-154, pp. 38–49, 2016. View at Publisher · View at Google Scholar
  • L E Laskaris, M A Di Biase, I Everall, G Chana, A Christopoulos, E Skafidas, V L Cropley, and C Pantelis, “Microglial activation and progressive brain changes in schizophrenia,” British Journal of Pharmacology, vol. 173, no. 4, pp. 666–680, 2016. View at Publisher · View at Google Scholar
  • Kenneth Asogwa, Carolina Nisenoff, and Jerome Okudo, “Foreign Accent Syndrome, a Rare Presentation of Schizophrenia in a 34-Year-Old African American Female: A Case Report and Literature Review,” Case Reports in Psychiatry, vol. 2016, pp. 1–5, 2016. View at Publisher · View at Google Scholar
  • Craig W. Lindsley, Kyle A. Emmitte, Corey R. Hopkins, Thomas M. Bridges, Karen J. Gregory, Colleen M. Niswender, and P. Jeffrey Conn, “Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors,” Chemical Reviews, 2016. View at Publisher · View at Google Scholar
  • Deanna L. Kelly, Laura M. Rowland, Kathleen M. Patchan, Kelli Sullivan, Amber Earl, Heather Raley, Fang Liu, Stephanie Feldman, and Robert P. McMahon, “Schizophrenia clinical symptom differences in women vs. men with and without a history of childhood physical abuse,” Child and Adolescent Psychiatry and Mental Health, vol. 10, no. 1, 2016. View at Publisher · View at Google Scholar
  • Yan-Yan Wei, Ji-Jun Wang, Chao Yan, Zi-Qiang Li, Xiao Pan, Yi Cui, Tong Su, Tao-Sheng Liu, and Yun-Xiang Tang, “Correlation Between Brain Activation Changes and Cognitive Improvement Following Cognitive Remediation Therapy in Schizophrenia: An Activation Likelihood Estimation Meta-analysis,” Chinese Medical Journal, vol. 129, no. 5, pp. 578, 2016. View at Publisher · View at Google Scholar
  • Bernard Crespi, Emma Leach, Natalie Dinsdale, Mikael Mokkonen, and Peter Hurd, “Imagination in human social cognition, autism, and psychotic-affective conditions,” Cognition, vol. 150, pp. 181–199, 2016. View at Publisher · View at Google Scholar
  • Manuela Ferrari, Nina Flora, Kelly K. Anderson, Asante Haughton, Andrew Tuck, Suzanne Archie, Sean Kidd, and Kwame McKenzie, “Gender differences in pathways to care for early psychosis,” Early Intervention in Psychiatry, 2016. View at Publisher · View at Google Scholar
  • JishaM Lucca, Madhan Ramesh, Dushad Ram, Jintu Kurian, and Noyal Mathew, “Psychotropic medication-induced sexual dysfunction and its interference with patient′s daily performance: a cross-sectional study,” Egyptian Journal of Psychiatry, vol. 37, no. 1, pp. 36, 2016. View at Publisher · View at Google Scholar
  • B. Moreno-Kuestner, F. Mayoral, D. Navas-Campana, J. M. Garcia-Herrera, P. Angona, C. Martin, and F. Rivas, “Prevalence of schizophrenia and related disorders in Malaga (Spain): results using multiple clinical databases,” Epidemiology And Psychiatric Sciences, vol. 25, no. 1, pp. 38–48, 2016. View at Publisher · View at Google Scholar
  • R. Daglas, S. M. Cotton, K. Allott, M. Yuecel, C. A. Macneil, M. K. Hasty, B. Murphy, C. Pantelis, K. T. Hallam, L. P. Henry, P. Conus, A. Ratheesh, L. Kader, M. Th Wong, P. D. McGorry, and M. Berk, “A single-blind, randomised controlled trial on the effects of lithium and quetiapine monotherapy on the trajectory of cognitive functioning in first e,” European Psychiatry, vol. 31, no. 1, pp. 20–28, 2016. View at Publisher · View at Google Scholar
  • Matt A. Brown, Ram J. Bishnoi, Sara Dholakia, and Dawn I. Velligan, “Methodological issues associated with preclinical drug development and increased placebo effects in schizophrenia clinical trials,” Expert Review of Clinical Pharmacology, pp. 1–14, 2016. View at Publisher · View at Google Scholar
  • Eva A. Malt, Katalin Juhasz, Ulrik F. Malt, and Thomas Naumann, “A Role for the Transcription Factor Nk2 Homeobox 1 in Schizophrenia: Convergent Evidence from Animal and Human Studies,” Frontiers in Behavioral Neuroscience, vol. 10, 2016. View at Publisher · View at Google Scholar
  • Elizabeth B. Torres, Robert W. Isenhower, Jillian Nguyen, Caroline Whyatt, John I. Nurnberger, Jorge V. Jose, Steven M. Silverstein, Thomas V. Papathomas, Jacob Sage, and Jonathan Cole, “Toward Precision Psychiatry: Statistical Platform for the Personalized Characterization of Natural Behaviors,” Frontiers in Neurology, vol. 7, 2016. View at Publisher · View at Google Scholar
  • Marcella Bellani, Filippo Boschello, Giuseppe Delvecchio, Nicola Dusi, Carlo Alfredo Altamura, Mirella Ruggeri, and Paolo Brambilla, “DTI and Myelin Plasticity in Bipolar Disorder: Integrating Neuroimaging and Neuropathological Findings,” Frontiers in Psychiatry, vol. 7, 2016. View at Publisher · View at Google Scholar
  • Elodie Peyroux, and Nicolas Franck, “Improving Social Cognition in People with Schizophrenia with RC2S: Two Single-Case Studies,” Frontiers in Psychiatry, vol. 7, 2016. View at Publisher · View at Google Scholar
  • Susana Mingote, Justine Masson, Celia Gellman, Gretchen M. Thomsen, Chyuan-Sheng Lin, Robert J. Merker, Inna Gaisler-Salomon, Yvonne Wang, Rachel Ernst, René Hen, and Stephen Rayport, “Genetic Pharmacotherapy as an Early CNS Drug Development Strategy: Testing Glutaminase Inhibition for Schizophrenia Treatment in Adult Mice,” Frontiers in Systems Neuroscience, vol. 9, 2016. View at Publisher · View at Google Scholar
  • Meng-Juan Jing, Wei-Quan Lin, Qiang Wang, Jia-Ji Wang, Jie Tang, En-She Jiang, Yi-Xiong Lei, and Pei-Xi Wang, “Reliability and Construct Validity of Two Versions of Chalder Fatigue Scale among the General Population in Mainland China,” International Journal of Environmental Research and Public Health, vol. 13, no. 2, pp. 147, 2016. View at Publisher · View at Google Scholar
  • Md. Nur Kabidul Azam, Md. Mizanur Rahman, Samanta Biswas, and Md. Nasir Ahmed, “Appraisals of Bangladeshi Medicinal Plants Used by Folk Medicine Practitioners in the Prevention and Management of Malignant Neoplastic Diseases,” International Scholarly Research Notices, vol. 2016, pp. 1–12, 2016. View at Publisher · View at Google Scholar
  • Brenda Happell, Robert Stanton, Danya Hodgetts, and David Scott, “Quality of Life Outcomes in Community-based Mental Health Consumers: Comparisons with Population Norms and Changes over Time,” Issues in Mental Health Nursing, pp. 1–7, 2016. View at Publisher · View at Google Scholar
  • Henderikus G. O. M. Smid, Richard Bruggeman, and Sander Martens, “Normal Cognitive Conflict Resolution in Psychosis Patients With and Without Schizophrenia,” Journal Of Abnormal Psychology, vol. 125, no. 1, pp. 88–103, 2016. View at Publisher · View at Google Scholar
  • Ugo Ikwuka, Niall Galbraith, Ken Manktelow, Josephine Chen-Wilson, Femi Oyebode, Rosemary C. Muomah, and Anuli Igboaka, “Ideological vs. Instrumental Barriers to Accessing Formal Mental Health care in the Developing World: Focus on South-eastern Nigeria,” Journal Of Health Care For The Poor And Underserved, vol. 27, no. 1, pp. 157–175, 2016. View at Publisher · View at Google Scholar
  • F. Shaddel, M. Ghazirad, D. O’Leary, and S. Banerjee, “How Psychotropic Drugs Are Used; an Explanatory Paradigm,” Journal of Medical Hypotheses and Ideas, 2016. View at Publisher · View at Google Scholar
  • Laura Nisenbaum, AnnCatherine Downing, Fangyi Zhao, Brian Millen, Leanne Munsie, Bruce Kinon, David Adams, Juan Gomez, and Michelle Penny, “Serotonin 2A Receptor SNP rs7330461 Association with Treatment Response to Pomaglumetad Methionil in Patients with Schizophrenia,” Journal of Personalized Medicine, vol. 6, no. 1, pp. 9, 2016. View at Publisher · View at Google Scholar
  • P. C. van der Ende, J. T. van Busschbach, J. Nicholson, E. L. Korevaar, and J. van Weeghel, “Strategies for parenting by mothers and fathers with a mental illness,” Journal of Psychiatric and Mental Health Nursing, 2016. View at Publisher · View at Google Scholar
  • Shayden Bryce, Elise Sloan, Stuart Lee, Jennie Ponsford, and Susan Rossell, “Cognitive remediation in schizophrenia: A methodological appraisal of systematic reviews and meta-analyses,” Journal of Psychiatric Research, 2016. View at Publisher · View at Google Scholar
  • Joseph Walsh, “Schizotypal Personality Disorder: A Clinical Social Work Perspective,” Journal of Social Work Practice, pp. 1–12, 2016. View at Publisher · View at Google Scholar
  • R-R Wu, F-Y Zhang, K-M Gao, J-J Ou, P Shao, H Jin, W-B Guo, P K Chan, and J-P Zhao, “Metformin treatment of antipsychotic-induced dyslipidemia: an analysis of two randomized, placebo-controlled trials,” Molecular Psychiatry, 2016. View at Publisher · View at Google Scholar
  • Andrea de Bartolomeis, Andrea Fagiolini, Marco Vaggi, and Claudio Vampini, “Targets, attitudes, and goals of psychiatrists treating patients with schizophrenia: key outcome drivers, role of quality of life, and place of long-a,” Neuropsychiatric Disease And Treatment, vol. 12, pp. 99–108, 2016. View at Publisher · View at Google Scholar
  • Jillian Nguyen, Ushma Majmudar, V. Papathomas Thomas, Steven M. Silverstein, and Elizabeth B. Torres, “Schizophrenia: The Micro-Movements Perspective,” Neuropsychologia, 2016. View at Publisher · View at Google Scholar
  • Antonio Vita, Giacomo Deste, Stefano Barlati, Roberto Poli, Paolo Cacciani, Luca De Peri, and Emilio Sacchetti, “Feasibility and effectiveness of cognitive remediation in the treatment of borderline personality disorder,” Neuropsychological Rehabilitation, pp. 1–13, 2016. View at Publisher · View at Google Scholar
  • H. Wu, X. Wang, Y. Gao, F. Lin, T. Song, Y. Zou, L. Xu, and H. Lei, “Nmda Receptor Antagonism By Repetitive Mk801 Administration Induces Schizophrenia-Like Structural Changes In The Rat Brain As Revealed By Voxel-Based ,” Neuroscience, vol. 322, pp. 221–233, 2016. View at Publisher · View at Google Scholar
  • Ali Mohammad Pourrahimi, Shahrzad Mazhari, Mohammad Shabani, Yousef Moghadas Tabrizi, and Vahid Sheibani, “Title: Numerical distance effect in patients with schizophrenia,” Neuroscience Letters, 2016. View at Publisher · View at Google Scholar
  • Seung A Lee, Chai-Youn Kim, and Seung-Hwan Lee, “Non-Conscious Perception of Emotions in Psychiatric Disorders: The Unsolved Puzzle of Psychopathology,” Psychiatry Investigation, vol. 13, no. 2, pp. 165, 2016. View at Publisher · View at Google Scholar
  • Robert-Paul Juster, Catherine Raymond, Alexandra Bisson Desrochers, Olivier Bourdon, Nadia Durand, Nathalie Wan, Jens C. Pruessner, and Sonia J. Lupien, “Sex hormones adjust “sex-specific” reactive and diurnal cortisol profiles,” Psychoneuroendocrinology, vol. 63, pp. 282–290, 2016. View at Publisher · View at Google Scholar
  • Mark Shevlin, Eoin McElroy, Mogens Nygaard Christoffersen, Ask Elklit, Philip Hyland, and Jamie Murphy, “Social, familial and psychological risk factors for psychosis: A birth cohort study using the Danish Registry System,” Psychosis, pp. 1–11, 2016. View at Publisher · View at Google Scholar
  • Kathryn E. Greenwood, Robin Morris, Vanessa Smith, Anna-Marie Jones, Douglas Pearman, and Til Wykes, “Virtual shopping: A viable alternative to direct assessment of real life function?,” Schizophrenia Research, 2016. View at Publisher · View at Google Scholar
  • Kelsey A. Bonfils, Paul H. Lysaker, Kyle S. Minor, and Michelle P. Salyers, “Affective empathy in schizophrenia: a meta-analysis,” Schizophrenia Research, 2016. View at Publisher · View at Google Scholar
  • June Ullevoldsæter Lystad, Erik Falkum, Vegard Øksendal Haaland, Helen Bull, Stig Evensen, Morris D. Bell, and Torill Ueland, “Neurocognition and occupational functioning in schizophrenia spectrum disorders: The MATRICS Consensus Cognitive Battery (MCCB) and workplace assessments,” Schizophrenia Research, vol. 170, no. 1, pp. 143–149, 2016. View at Publisher · View at Google Scholar
  • Thais Rabanea-Souza, Henrique T. Akiba, Arthur A. Berberian, Rodrigo A. Bressan, Álvaro M. Dias, and Acioly L.T. Lacerda, “Neuropsychological correlates of remission in chronic schizophrenia subjects: The role of general and task-specific executive processes,” Schizophrenia Research: Cognition, vol. 3, pp. 39–46, 2016. View at Publisher · View at Google Scholar
  • S. M. Cotton, K. M. Filia, A. Ratheesh, K. Pennell, S. Goldstone, and P. D. McGorry, “Early psychosis research at Orygen, The National Centre of Excellence in Youth Mental Health,” Social Psychiatry And Psychiatric Epidemiology, vol. 51, no. 1, pp. 1–13, 2016. View at Publisher · View at Google Scholar
  • Martina Klein, Michaela Schmoeger, Siegfried Kasper, and Alexandra Schosser, “Meta-analysis of the COMT Val158Met polymorphism in major depressive disorder: the role of gender,” World Journal Of Biological Psychiatry, vol. 17, no. 2, pp. 147–158, 2016. View at Publisher · View at Google Scholar
  • Terrell Holloway, and Javier Gonzalez-Maeso, “Epigenetic Mechanisms of Serotonin Signaling,” Acs Chemical Neuroscience, vol. 6, no. 7, pp. 1099–1109, 2015. View at Publisher · View at Google Scholar
  • M. Möller, T. Swanepoel, and B. H. Harvey, “Neurodevelopmental Animal Models Reveal the Convergent Role of Neurotransmitter Systems, Inflammation, and Oxidative Stress as Biomarkers of Schizophrenia: Implications for Novel Drug Development,” ACS Chemical Neuroscience, pp. 150402134223006, 2015. View at Publisher · View at Google Scholar
  • Rosaria Di Lorenzo, Alessandra Amoretti, Samantha Baldini, Marcello Soli, Giulia Landi, Gabriella Pollutri, Rossella Corradini, and Paola Ferri, “Homocysteine levels in schizophrenia patients newly admitted to an acute psychiatric ward,” Acta Neuropsychiatrica, vol. 27, no. 6, pp. 336–344, 2015. View at Publisher · View at Google Scholar
  • M. De Hert, J. Peuskens, T. Sabbe, A. J. Mitchell, B. Stubbs, P. Neven, H. Wildiers, and J. Detraux, “Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review,” Acta Psychiatrica Scandinavica, 2015. View at Publisher · View at Google Scholar
  • A. L. Sutterland, G. Fond, A. Kuin, M. W. J. Koeter, R. Lutter, T. van Gool, R. Yolken, A. Szoke, M. Leboyer, and L. de Haan, “ Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis ,” Acta Psychiatrica Scandinavica, 2015. View at Publisher · View at Google Scholar
  • Menka Tsantefski, Alun C. Jackson, and Cathy Humphreys, “A delicate balance: intervention with mothers with dual diagnosis and their infants,” Advances in Dual Diagnosis, vol. 8, no. 2, pp. 78–89, 2015. View at Publisher · View at Google Scholar
  • Ian Hamilton, Paul Galdas, and Holly Essex, “Cannabis psychosis, gender matters,” Advances in Dual Diagnosis, vol. 8, no. 3, pp. 153–162, 2015. View at Publisher · View at Google Scholar
  • Sadao Otsuka, Mie Matsui, Takatoshi Hoshino, Kayoko Miura, Yuko Higuchi, and Michio Suzuki, “The Effectiveness and Applicability of Compensatory Cognitive Training for Japanese Patients with Schizophrenia: A Pilot Study,” Advances in Psychiatry, vol. 2015, pp. 1–12, 2015. View at Publisher · View at Google Scholar
  • Marcelo Valencia, Juan A. Moriana, Alex Kopelowicz, Steven R. Lopez, and Robert P. Liberman, “Social-Skills Training for Spanish-Speaking Persons with Schizophrenia: Experiences From Latin America, Spain, and the United States,” American Journal of Psychiatric Rehabilitation, vol. 18, no. 3, pp. 209–246, 2015. View at Publisher · View at Google Scholar
  • Marsal Sanches, Isabelle E. Bauer, Juan F. Galvez, Giovana B. Zunta-Soares, and Jair C. Soares, “The Management of Cognitive Impairment in Bipolar Disorder: Current Status and Perspectives,” American Journal Of Therapeutics, vol. 22, no. 6, pp. 477–486, 2015. View at Publisher · View at Google Scholar
  • Anne Gut-Fayand, “Éducation thérapeutique du patient et schizophrénies débutantes,” Annales Médico-psychologiques, revue psychiatrique, 2015. View at Publisher · View at Google Scholar
  • Federica Pinna, Luca Deriu, Enrica Diana, Valeria Perra, Rachele Pisu Randaccio, Lucia Sanna, Massimo Tusconi, and Bernardo Carpiniello, “Clinical Global Impression-severity score as a reliable measure for routine evaluation of remission in schizophrenia and schizoaffective disorders,” Annals of General Psychiatry, vol. 14, no. 1, 2015. View at Publisher · View at Google Scholar
  • Kiran Jakhar, Triptish Bhatia, Rahul Saha, and Smita Deshpande, “A Cross Sectional Study of Prevalence and Correlates of Current and Past Risks in Schizophrenia,” Asian Journal of Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Jayashri Kulkarni, and Kate Reeve-Parker, “Psychiatrists' awareness of partial- and non-adherence to antipsychotic medication in schizophrenia: results from the Australian ADHES survey,” Australasian Psychiatry, vol. 23, no. 3, pp. 258–264, 2015. View at Publisher · View at Google Scholar
  • Antonio Vita, Luca De Peri, Giacomo Deste, Stefano Barlati, and Emilio Sacchetti, “The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies,” Biological Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Christina Daniel, and Oliver J. Mason, “Predicting Psychotic-Like Experiences during Sensory Deprivation,” BioMed Research International, vol. 2015, pp. 1–10, 2015. View at Publisher · View at Google Scholar
  • Christina Daniel, and Oliver J. Mason, “Predicting Psychotic-Like Experiences during Sensory Deprivation,” Biomed Research International, 2015. View at Publisher · View at Google Scholar
  • Chung-Chieh Hung, and Yung-Wen Ku, “Influencing and moderating factors analyzed in the group art therapy of two schizophrenic inpatients,” BioMedicine, vol. 5, no. 4, 2015. View at Publisher · View at Google Scholar
  • Annika Rose, Sophia Vinogradov, Melissa Fisher, Michael F. Green, Joseph Ventura, Christine Hooker, Michael Merzenich, and Mor Nahum, “Randomized controlled trial of computer-based treatment of social cognition in schizophrenia: the TRuSST trial protocol,” Bmc Psychiatry, vol. 15, 2015. View at Publisher · View at Google Scholar
  • Zhi Zhang, and Henriette van Praag, “Maternal immune activation differentially impacts mature and adult-born hippocampal neurons in male mice,” Brain, Behavior, and Immunity, vol. 45, pp. 60–70, 2015. View at Publisher · View at Google Scholar
  • Marjolaine Masson, Til Wykes, Michel Maziade, Clare Reeder, Marie-Anne Gariépy, Marc-André Roy, Hans Ivers, and Caroline Cellard, “Top-Down Computerized Cognitive Remediation in Schizophrenia: A Case Study of an Individual with Impairment in Verbal Fluency,” Case Reports in Psychiatry, vol. 2015, pp. 1–10, 2015. View at Publisher · View at Google Scholar
  • Michael J. Waterson, and Tamas L. Horvath, “Neuronal Regulation of Energy Homeostasis: Beyond the Hypothalamus and Feeding,” Cell Metabolism, 2015. View at Publisher · View at Google Scholar
  • Jancy Jose, H. Nandeesha, Shivanand Kattimani, Kavitha Meiyappan, Siddharth Sarkar, and Devanarayanan S, “Association between prolactin and thyroid hormones with severity of psychopathology and suicide risk in drug free male schizophrenia,” Clinica Chimica Acta, 2015. View at Publisher · View at Google Scholar
  • lement Zai Ali Bani Fatemi C, and Vincenzo De Luca, “Early Onset Schizophrenia: Gender Analysis of Genome-Wide Potential Methylation,” Clinica Chimica Acta, 2015. View at Publisher · View at Google Scholar
  • Sarah Reeve, Bryony Sheaves, and Daniel Freeman, “The role of sleep dysfunction in the occurrence of delusions and hallucinations: A systematic review,” Clinical Psychology Review, vol. 42, pp. 96–115, 2015. View at Publisher · View at Google Scholar
  • Marc De Hert, Jan Sermon, Paul Geerts, Kristof Vansteelandt, Joseph Peuskens, and Johan Detraux, “The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics,” CNS Drugs, 2015. View at Publisher · View at Google Scholar
  • Anna E. Ordonez, Nevin V. Sastry, and Nitin Gogtay, “Functional and clinical insights from neuroimaging studies in childhood-onset schizophrenia,” Cns Spectrums, vol. 20, no. 4, pp. 442–450, 2015. View at Publisher · View at Google Scholar
  • Björn Schlier, Sylvia Helbig-Lang, and Tania Marie Lincoln, “Anxious but Thoroughly Informed? No Jumping-to-Conclusions Bias in Social Anxiety Disorder,” Cognitive Therapy and Research, 2015. View at Publisher · View at Google Scholar
  • Steffen Moritz, Helena Mayer-Stassfurth, Lisa Endlich, Christina Andreou, Nora Ramdani, Franz Petermann, and Ryan P. Balzan, “The Benefits of Doubt: Cognitive Bias Correction Reduces Hasty Decision-Making in Schizophrenia,” Cognitive Therapy and Research, 2015. View at Publisher · View at Google Scholar
  • Mercedes Hernandez, and Concepción Barrio, “Perceptions of Subjective Burden Among Latino Families Caring for a Loved One with Schizophrenia,” Community Mental Health Journal, 2015. View at Publisher · View at Google Scholar
  • Susana Ochoa, Francisco Martínez-Zambrano, Mar Garcia-Franco, Sonia Vilamala, Maria Ribas, Oti Arenas, Esther Garcia-Morales, Irene Álvarez, Gemma Escartin, Raul Villellas, Maria Jose Escandell, Mónica Martínez-Raves, Elisabeth López-Arias, Christian Cunyat, and Josep Maria Haro, “Development and validation of the Self-Stigma Questionnaire (SSQ) for people with schizophrenia and its relation to social functioning,” Comprehensive Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Robert A. Renes, Neeltje E.M. van Haren, and Henk Aarts, “Attentional control and inferences of agency: Working memory load differentially modulates goal-based and prime-based agency experiences,” Consciousness and Cognition, vol. 38, pp. 38–49, 2015. View at Publisher · View at Google Scholar
  • Christophe E. de Bézenac, Vanessa Sluming, Noreen O’Sullivan, and Rhiannon Corcoran, “Ambiguity between self and other: Individual differences in action attribution,” Consciousness and Cognition, vol. 35, pp. 1–15, 2015. View at Publisher · View at Google Scholar
  • Katherine L. Narr, and Amber M. Leaver, “Connectome and schizophrenia,” Current Opinion in Psychiatry, vol. 28, no. 3, pp. 229–235, 2015. View at Publisher · View at Google Scholar
  • Elizabeth A. Klingaman, Jessica Palmer-Bacon, Melanie E. Bennett, and Laura M. Rowland, “Sleep Disorders Among People With Schizophrenia: Emerging Research,” Current Psychiatry Reports, vol. 17, no. 10, 2015. View at Publisher · View at Google Scholar
  • Foteini Tseliou, Sonia Johnson, Barnaby Major, Nikola Rahaman, John Joyce, Jo Lawrence, Farhana Mann, Andrew Tapfumaneyi, Brock Chisholm, Nick Chamberlain-Kent, Mark F. Hinton, and Helen L. Fisher, “Gender differences in one-year outcomes of first-presentation psychosis patients in inner-city UK Early Intervention Services,” Early Intervention in Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Shirlene Pang, Mythily Subramaniam, Edimansyah Abdin, Lye Yin Poon, Siow Ann Chong, and Swapna Verma, “Gender differences in patients with first-episode psychosis in the Singapore Early Psychosis Intervention Programme,” Early Intervention in Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Andrew Tapfumaneyi, Sonia Johnson, John Joyce, Barnaby Major, Jo Lawrence, Farhana Mann, Brock Chisholm, Nikola Rahaman, James Wooley, and Helen L. Fisher, “Predictors of vocational activity over the first year in inner-city early intervention in psychosis services,” Early Intervention In Psychiatry, vol. 9, no. 6, pp. 447–458, 2015. View at Publisher · View at Google Scholar
  • Cenk Tek, Suat Kucukgoncu, Sinan Guloksuz, Scott W. Woods, Vinod H. Srihari, and Aniyizhai Annamalai, “Antipsychotic-induced weight gain in first-episode psychosis patients: a meta-analysis of differential effects of antipsychotic medications,” Early Intervention in Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Andrea Spitz, Erich Studerus, Susan Koranyi, Charlotte Rapp, Avinash Ramyead, Sarah Ittig, Ulrike Heitz, Martina Uttinger, and Anita Riecher-Rössler, “Correlations between self-rating and observer-rating of psychopathology in at-risk mental state and first-episode psychosis patients: influence of disease stage and gender,” Early Intervention in Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Marcelino López Alvarez, and Margarita Laviana Cuetos, “La coordinación sociosanitaria en la atención a personas con trastornos mentales graves,” Enfermería Clínica, 2015. View at Publisher · View at Google Scholar
  • Ruth A. Lanius, Paul A. Frewen, Mischa Tursich, Rakesh Jetly, and Margaret C. McKinnon, “Restoring large-scale brain networks in PTSD and related disorders: a proposal for neuroscientifically-informed treatment interventions,” European Journal of Psychotraumatology, vol. 6, no. 0, 2015. View at Publisher · View at Google Scholar
  • Leticia S. Czepielewski, Raffael Massuda, Pedro Goi, Mireia Sulzbach-Vianna, Ramiro Reckziegel, Monise Costanzi, Flavio Kapczinski, Adriane R. Rosa, and Clarissa S. Gama, “Verbal episodic memory along the course of schizophrenia and bipolar disorder: A new perspective,” European Neuropsychopharmacology, vol. 25, no. 2, pp. 169–175, 2015. View at Publisher · View at Google Scholar
  • Tseng Ping-Tao, Cheng Yu-Shian, Chen Yen-Wen, Wu Ching-Kuan, and Lin Pao-Yen, “Increased levels of vascular endothelial growth factor in patients with major depressive disorder: A meta-analysis,” European Neuropsychopharmacology, 2015. View at Publisher · View at Google Scholar
  • E. Chubarov, E. Sommerfeld, H. Hermesh, G. Shoval, M. Weiser, and G. Zalsman, “Dynamic occupation assessment of executive function in adolescents with schizophrenia spectrum disorders: An initial report,” European Psychiatry, vol. 30, no. 8, pp. 894–899, 2015. View at Publisher · View at Google Scholar
  • B. Chiliza, L. Asmal, P. Oosthuizen, E. Van Niekerk, R. Erasmus, M. Kidd, A. Malhotra, and R. Emsley, “Changes in body mass and metabolic profiles in patients with first-episode schizophrenia treated for 12 months with a first-generation antipsychotic,” European Psychiatry, vol. 30, no. 2, 2015. View at Publisher · View at Google Scholar
  • S. Ittig, E. Studerus, M. Papmeyer, M. Uttinger, S. Koranyi, A. Ramyead, and A. Riecher-Roessler, “Sex differences in cognitive functioning in at-risk mental state for psychosis, first episode psychosis and healthy control subjects,” European Psychiatry, vol. 30, no. 2, 2015. View at Publisher · View at Google Scholar
  • S. Moritz, B. Cludius, B. Hottenrott, B. C. Schneider, K. Saathoff, A. K. Kuelz, and J. Gallinat, “Mindfulness and relaxation treatment reduce depressive symptoms in individuals with psychosis,” European Psychiatry, vol. 30, no. 6, pp. 709–714, 2015. View at Publisher · View at Google Scholar
  • Bernard J. Crespi, and Matthew C. Go, “Diametrical diseases reflect evolutionary-genetic tradeoffs,” Evolution, Medicine, and Public Health, vol. 2015, no. 1, pp. 216–253, 2015. View at Publisher · View at Google Scholar
  • Mikael Mokkonen, and Bernard J. Crespi, “Genomic conflicts and sexual antagonism in human health: insights from oxytocin and testosterone,” Evolutionary Applications, 2015. View at Publisher · View at Google Scholar
  • Meng-Lin Li, Sha-Sha Yang, Bo Xing, Brielle R. Ferguson, Yelena Gulchina, Yan-Chun Li, Feng Li, Xi-Quan Hu, and Wen-Jun Gao, “LY395756, an mGluR2 agonist and mGluR3 antagonist, enhances NMDA receptor expression and function in the normal adult rat prefrontal cortex, but fails,” Experimental Neurology, vol. 273, pp. 190–201, 2015. View at Publisher · View at Google Scholar
  • Takefumi Suzuki, “A further consideration on long-acting injectable versus oral antipsychotics in the treatment of schizophrenia: a narrative review and critical appraisal,” Expert Opinion on Drug Delivery, pp. 1–12, 2015. View at Publisher · View at Google Scholar
  • Jan Malte Bumb, Frank Enning, and F Markus Leweke, “Drug repurposing and emerging adjunctive treatments for schizophrenia,” Expert Opinion on Pharmacotherapy, pp. 1–19, 2015. View at Publisher · View at Google Scholar